Citation: V. Schirrmacher, TUMOR VACCINE DESIGN - CONCEPTS, MECHANISMS, AND EFFICACY TESTING, International archives of allergy and immunology, 108(4), 1995, pp. 340-344
Authors:
SCHIRRMACHER V
OCKERT D
HAGMULLER E
SAEGER HD
Citation: V. Schirrmacher et al., NEWCASTLE-DISEASE VIRUS-INFECTED INTACT AUTOLOGOUS TUMOR-CELL VACCINEFOR ADJUVANT ACTIVE SPECIFIC IMMUNOTHERAPY OF RESECTED COLORECTAL-CARCINOMA, European journal of cancer, 31A, 1995, pp. 999-999
Citation: V. Schirrmacher et al., ACTIVE SPECIFIC IMMUNOTHERAPY WITH NEWCASTLE-DISEASE VIRUS MODIFIED AUTOLOGOUS TUMOR-CELLS, European journal of cancer, 31A, 1995, pp. 20-20
Authors:
POMER S
SCHUTH J
SCHIRRMACHER V
STAEHLER G
Citation: S. Pomer et al., 4-YEAR SURVIVAL-DATA OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH AUTOLOGOUS TUMOR VACCINE AND SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA (2B), European journal of cancer, 31A, 1995, pp. 44-44
Authors:
LICHTNER RB
KAUFMANN AM
KITTMANN A
ROHDESCHULZ B
WALTER J
WILLIAMS L
ULLRICH A
SCHIRRMACHER V
KHAZAIE K
Citation: Rb. Lichtner et al., LIGAND-MEDIATED ACTIVATION OF ECTOPIC EGF RECEPTOR PROMOTES MATRIX PROTEIN ADHESION AND LUNG COLONIZATION OF RAT MAMMARY ADENOCARCINOMA CELLS, Oncogene, 10(9), 1995, pp. 1823-1832
Authors:
CHLICHLIA K
MOLDENHAUER G
DANIEL PT
BUSSLINGER M
GAZZOLO L
SCHIRRMACHER V
KHAZAIE K
Citation: K. Chlichlia et al., IMMEDIATE EFFECTS OF REVERSIBLE HTLV-1 TAX FUNCTION - T-CELL ACTIVATION AND APOPTOSIS, Oncogene, 10(2), 1995, pp. 269-277
Authors:
POMER S
THIELE R
STAEHLER G
DREHMER I
LOHRKE H
SCHIRRMACHER V
Citation: S. Pomer et al., TUMOR VACCINATION WITH AND WITHOUT ADJUVA NT INTERLEUKIN-2 IN RENAL-CELL CARCINOMA - A CLINICAL CONTRIBUTION TO THE DEVELOPMENT OF EFFECTIVE ACTIVE SPECIFIC IMMUNIZATION, Der Urologe, 34(3), 1995, pp. 215-220
Citation: V. Schirrmacher, BIOTHERAPY OF CANCER - PERSPECTIVES OF IMMUNOTHERAPY AND GENE-THERAPY, Journal of cancer research and clinical oncology, 121(8), 1995, pp. 443-451
Citation: V. Schirrmacher et al., WORKSHOP - ACTIVE SPECIFIC IMMUNOTHERAPY WITH TUMOR-CELL VACCINES - HEIDELBERG, GERMANY, NOVEMBER 1994, Journal of cancer research and clinical oncology, 121(8), 1995, pp. 487-489
Authors:
HAGMULLER E
BECK N
OCKERT D
SCHIRRMACHER V
Citation: E. Hagmuller et al., ADJUVANT THERAPY OF LIVER METASTASES - AC TIVE SPECIFIC IMMUNOTHERAPY, Zentralblatt fur Chirurgie, 120(10), 1995, pp. 780-785
Authors:
ROCHA M
KRUGER A
VANROOIJEN N
SCHIRRMACHER V
UMANSKY V
Citation: M. Rocha et al., LIVER ENDOTHELIAL-CELLS PARTICIPATE IN T-CELL-DEPENDENT HOST-RESISTANCE TO LYMPHOMA METASTASIS BY PRODUCTION OF NITRIC-OXIDE IN-VIVO, International journal of cancer, 63(3), 1995, pp. 405-411
Citation: J. Walter et al., INDUCTION OF CD44 EXPRESSION BY THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN LMP1 IS ASSOCIATED WITH LYMPHOMA DISSEMINATION (VOL 61, PG 363, 1995), International journal of cancer, 63(2), 1995, pp. 318-318
Citation: J. Walter et al., INDUCTION OF CD44 EXPRESSION BY THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN LMP1 IS ASSOCIATED WITH LYMPHOMA DISSEMINATION, International journal of cancer, 61(3), 1995, pp. 363-369
Authors:
VERSCHUEREN H
DEWIT J
DEBRAEKELEER J
SCHIRRMACHER V
DEBAETSELIER P
Citation: H. Verschueren et al., MOTILITY AND INVASIVE POTENCY OF MURINE T-LYMPHOMA CELLS - EFFECT OF MICROTUBULE INHIBITORS, Cell biology international, 18(1), 1994, pp. 11-19
Authors:
SCHIRRMACHER V
GRIESBACH A
UMANSKY V
ROCHA M
Citation: V. Schirrmacher et al., ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS, International journal of oncology, 5(2), 1994, pp. 141-151
Authors:
KAUFMANN AM
KHAZAIE K
WIEDEMUTH M
ROHDESCHULZ B
ULLRICH A
SCHIRRMACHER V
LICHTNER RB
Citation: Am. Kaufmann et al., EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR CORRELATES WITH METASTATIC POTENTIAL OF 13762NF RAT MAMMARY ADENOCARCINOMA CELLS, International journal of oncology, 4(6), 1994, pp. 1149-1155
Citation: V. Schirrmacher et U. Zangemeisterwittke, GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER, International journal of oncology, 4(2), 1994, pp. 335-346
Authors:
GRUNICKE H
PYERIN W
EISENBRAND G
HAVEMANN K
RABES HM
MOLLING K
SCHWAB M
LUTZ WK
WAHRENDORF J
SCHIRRMACHER V
BOSSLET K
Citation: H. Grunicke et al., 7TH INTERNATIONAL-SYMPOSIUM OF THE DIVISION OF EXPERIMENTAL CANCER-RESEARCH (AEK) OF THE GERMAN-CANCER-SOCIETY - 24-26 MARCH, 1993, HEIDELBERG, GERMANY, Journal of cancer research and clinical oncology, 120(3), 1994, pp. 179-185
Authors:
KHAZAIE K
PRIFTI S
BECKHOVE P
GRIESBACH A
RUSSELL S
COLLINS M
SCHIRRMACHER V
Citation: K. Khazaie et al., PERSISTENCE OF DORMANT TUMOR-CELLS IN THE BONE-MARROW OF TUMOR CELL-VACCINATED MICE CORRELATES WITH LONG-TERM IMMUNOLOGICAL PROTECTION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(16), 1994, pp. 7430-7434
Authors:
PLAKSIN D
PORGADOR A
VADAI E
FELDMAN M
SCHIRRMACHER V
EISENBACH L
Citation: D. Plaksin et al., EFFECTIVE ANTIMETASTATIC MELANOMA VACCINATION WITH TUMOR-CELLS TRANSFECTED WITH MHC GENES AND OR INFECTED WITH NEWCASTLE-DISEASE VIRUS (NDV)/, International journal of cancer, 59(6), 1994, pp. 796-801
Citation: A. Kruger et al., SCATTERED MICROMETASTASES VISUALIZED AT THE SINGLE-CELL LEVEL - DETECTION AND RE-ISOLATION OF LACZ-LABELED METASTASIZED LYMPHOMA-CELLS, International journal of cancer, 58(2), 1994, pp. 275-284
Citation: T. Kaido et al., SUCCESSFUL IMMUNOTHERAPY OF THE HIGHLY METASTATIC MURINE ESB LYMPHOMAWITH SENSITIZED CD8-CELLS AND IFN-ALPHA( T)BETA/, International journal of cancer, 57(4), 1994, pp. 538-543
Authors:
KRUGER A
UMANSKY V
ROCHA M
HACKER HJ
SCHIRRMACHER V
VONHOEGEN P
Citation: A. Kruger et al., PATTERN AND LOAD OF SPONTANEOUS LIVER METASTASIS DEPENDENT ON HOST IMMUNE STATUS STUDIED WITH A LACZ TRANSDUCED LYMPHOMA, Blood, 84(9), 1994, pp. 3166-3174